Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Johnson & Johnson Probe Widens Over Children's Tylenol

Posted by Jane Akre
Wednesday, May 26, 2010 12:44 PM EST
Category: Protecting Your Family
Tags: Tylenol, Johnson & Johnson, McNeil Healthcare, FDA, Recall

J & J Exec To Appear At Hearing Thursday


IMAGE SOURCE: image of Tylenol probe, Committee on Oversight and Government Reform Web site

The news keeps getting worse for Johnson & Johnson (J & J), maker of children‘s Tylenol.

Health regulators are now expanding their look at complications from infant and child medications made by J & J, including 30 deaths.

So far no direct link has been established between an April 30th recall of 40 types of children’s pain and allergy medications made by J & J subsidiary, McNeil Healthcare, and 775 reported adverse events, according to a congressional report released Tuesday.

The House Oversight and Government Reform Committee has been investigating J & J ever since its Fort Washington, Pennsylvania manufacturing facility was closed following an FDA inspection.

The FDA, in its April inspection report, found holes in the ceiling, filthy equipment, bacterial contamination (B. cepacia) and inconsistencies in the active ingredient in children’s cold medicines that could result in "super potent" formulations.

The report led to the recall of more than 40 child and infant medications on April 30.

The report says ever since the recall, several hundred more adverse reports have come into the FDA, including seven deaths.

“At this time, FDA is not aware of any child being harmed by taking one of the recalled products," said the staff report, dated May 24.

"FDA is still investigating some of these adverse events to determine if the events were related to a child taking one of the recalled medicines” reports Reuters.

The FDA still says the chance of being sickened from the more potent active formulations is “remote,” although the agency did go out on a limb by publicly suggesting parents choose generics over the J & J / McNeil brands.

On Thursday at 10 a.m., the committee will convene a live hearing gathering FDA officials and J & J over the manufacturing lapses.

The head of J & J, William Weldon, is expected to be the first witness.

On April 30, McNeil Consumer Healthcare, a subsidiary of Johnson and Johnson recalled infant and children’s versions of Motrin, Benadryl and Zyrtec, along with children’s Tylenol pain reliever and other mediations, in all about 70% of the children’s over-the-market liquid medications.

It was the largest recall of children’s medicine in the history of the FDA the congressional staff reports and the third recall of McNeil product over the last eight months. #

1 Comment

Posted by Jane Akre
Thursday, May 27, 2010 1:15 PM EST

Speaking now is Ms. Colleen A. Goggins, worldwide chairman of J & J’s Consumer Group who says there was no danger to consumers by the problematic child and infant J&J products. Company is undergoing shifts of executives overseeing safety and manufacturing.

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address


RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes